login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ALLAKOS INC (ALLK) Stock News
USA
- NASDAQ:ALLK -
US01671P1003
-
Common Stock
0.3291
USD
0 (-0.06%)
Last: 5/14/2025, 8:18:43 PM
0.3285
USD
0 (-0.18%)
After Hours:
5/14/2025, 8:18:43 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ALLK Latest News, Press Relases and Analysis
All
Press Releases
7 months ago - By: Benzinga
- Mentions:
SCLX
SBFM
IBO
SYRA
...
12 Health Care Stocks Moving In Wednesday's Intraday Session
9 months ago - By: Benzinga
Why Is Allakos Stock Plunging On Monday?
a year ago - By: BusinessInsider
ALLK Stock Earnings: Allakos Beats EPS for Q2 2024
a year ago - By: InvestorPlace
ALLK Stock Earnings: Allakos Beats EPS for Q2 2024
7 months ago - By: Halper Sadeh LLC
- Mentions:
RDFN
COOP
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, RDFN, ALLK on Behalf of Shareholders
7 months ago - By: Halper Sadeh LLC
ALLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Allakos Inc. Is Fair to Shareholders
7 months ago - By: Ademi & Fruchter LLP
Shareholder Alert: The Ademi Firm Investigates Whether Allakos Inc. Is Obtaining a Fair Price for Its Public Shareholders
7 months ago - By: Allakos Inc.
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
7 months ago - By: Allakos Inc.
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
7 months ago - By: Allakos Inc.
Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
7 months ago - By: Allakos Inc.
Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results
9 months ago - By: Stocktwits
Allakos Stock Craters To Record Low On Lead Drug Setback: Retail Hopes Fade
9 months ago - By: Allakos Inc.
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
9 months ago - By: Allakos Inc.
Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring
10 months ago - By: Kuehn Law, PLLC
Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm
a year ago - By: Allakos Inc.
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results
a year ago - By: Allakos Inc.
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
a year ago - By: Allakos Inc.
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
a year ago - By: Allakos Inc.
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
Please enable JavaScript to continue using this application.